Oxidative stress and breast cancer biomarkers: the case of the cytochrome P450 2E1

Abstract

Aim: The aim of the study is to investigate the impact of the cytochrome P450 2E1, which is the most efficient CYP450 family member in generating reactive oxygen species (ROS), on cellular energy metabolism of breast cancer cells and therefore the effects of CYP2E1 on breast carcinogenesis. Methods: The estrogen receptor positive MCF-7 and the triple negative MDA-MB-231 breast cancer cells were used as experimental system to estimate ROS generation in these cells overexpressing CYP2E1 and treated with the glycolytic inhibitors 3-bromopyruvate or 2-deoxyglucose in the presence or absence of the CYP2E1 inhibitor chlormethiazole. Adenosine triphosphate (ATP) assay was used to measure ATP production and lactate assay to quantify the efflux of lactic acid in breast cancer cells treated with the CYP2E1 inhibitor chlormethiazole, the mitochondrial membrane potential and cell viability assays were employed to assess the pathway of cellular energy production and cellular death respectively after treatment of MCF-7 and MDA-MB-231 with the CYP2E1 activator acetaminophen or the CYP2E1 inhibitor chlormethiazole. Results: The results indicated increased ROS generation in breast cancer cells overexpressing CYP2E1. ROS generation was differentially regulated in breast cancer cells upon treatment with the CYP2E1 inhibitor chlormethiazole. Chlormethiazole treated MCF-7 cells exhibited reduced lactate efflux implying that CYP2E1 directly or indirectly regulates the glycolytic rate in these cells. Furthermore the mitochondrial membrane potential of both MCF-7 and MDA-MB-231 cells was differentially affected by the CYP2E1 activator acetaminophen versus the CYP2E1 inhibitor chlormethiazole providing additional support for the involvement of CYP2E1 in energy metabolic pathways in breast cancer. Conclusion: Results presented in this study provide evidence to suggest that CYP2E1 regulates cellular energy metabolism of breast cancer cells in a manner dependent on cell type and potentially on the clinical staging of the disease therefore CYP2E1 is a possible breast cancer biomarker.

Keywords

Reactive oxygen species / cytochrome P450 2E1 / glycolysis / breast cancer

References

[1] Lenaz G,Barbero G,Dalmonte ME,Faccioli M,Fato R,Sgarbi G.Mitochondrial respiratory chain super-complex I-III in physiology and pathology..Biochim Biophys Acta2010;1797:633-40

[2] Schieber M.ROS Function in Redox Signaling and Oxidative Stress..Current Biology2014;24:R453-62

[3] Burhans WC.The cell cycle is a redox cycle: linking phase-specific targets to cell fate..Free Radic Biol Med2009;47:1282-93

[4] Dewaele M,Agostinis P.ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy..Autophagy2010;6:838-54

[5] Azad MB,Gibson SB.Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment..Antioxid Redox Signal2009;11:777-90

[6] Wu WS.The signaling mechanism of ROS in tumor progression..Cancer Metastasis Rev2006;25:695-705

[7] Bhandary B,Kim HR.An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases..Int J Mol Sci2012;14:434-56 PMCID:PMC3565273

[8] Sullivan LB.Mitochondrial reactive oxygen species and cancer..Cancer Metab2014;2:17 PMCID:PMC4323058

[9] Quijano C,Castro L.Interplay between oxidant species and energy metabolism..Redox biology2016;8:28-42 PMCID:PMC4710798

[10] Holmstrom KM.Cellular mechanisms and physiological consequences of redox-dependent signalling..Nat Rev Mol Cell Biol2014;15:411-21

[11] Coon MJ.Cytochrome P450: nature's most versatile biological catalyst..Annu Rev Pharmacol Toxicol2005;45:1-25

[12] Hrycay EG.Monooxygenase, peroxidase and peroxygenase properties and reaction mechanisms of cytochrome P450 enzymes..Adv Exp Med Biol2015;851:1-61

[13] Gonzalez FJ.Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1..Mutat Res2005;569:101-10

[14] Tamasi V,Prough RA.Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s..Cell Mol Life Sci2011;68:1131-46

[15] McFadyen MC,Murray GI.Cytochrome P450 enzymes: novel options for cancer therapeutics..Mol Cancer Ther2004;3:363-71

[16] Iscan M,Coban T,Pelkonen O.The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue..Breast Cancer Res Treat2001;70:47-54

[17] Kapucuoglu N,Raunio H,Edwards RJ,Iscan M.Immunohistochemical demonstration of the expression of CYP2E1 in human breast tumour and non-tumour tissues..Cancer Lett2003;196:153-9

[18] Morgan ET,Piquette-Miller M,Robertson GR,Charles KA,Kacevska M,Richardson TA,Sinal CJ.Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer..Drug Metab Dispos2008;36:205-16

[19] Zordoky BN.Role of NF-kappaB in the regulation of cytochrome P450 enzymes..Curr Drug Metab2009;10:164-78

[20] Wang J,Nekvindova J,Neve EP.IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways..Biochem Pharmacol2010;80:1592-600

[21] Millonig G,Homann N,Qin H,Bartsch H.Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions..Int J Cancer2011;128:533-40

[22] Wang S,Tung A,Grant DM.N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer..Toxicol Sci2015;144:393-405 PMCID:PMC4372667

[23] Kang JS,Morimura K,Fukushima S.Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo..Cancer Res2007;67:11141-6

[24] Miller TW,Roberts DD.Molecular regulation of tumor angiogenesis and perfusion via redox signaling..Chem Rev2009;109:3099-124 PMCID:PMC2801866

[25] Scherz-Shouval R.Regulation of autophagy by ROS: physiology and pathology..Trends Biochem Sci2011;36:30-8

[26] Ravikumar B,Davies JE,Garcia-Arencibia M,Jimenez-Sanchez M,Lichtenberg M,Massey DC,Moreau K,Renna M,Underwood BR,Rubinsztein DC.Regulation of mammalian autophagy in physiology and pathophysiology..Physiol Rev2010;90:1383-435

[27] Kim I,Reed JC.Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities..Nat Rev Drug Discov2008;7:1013-30

[28] Rutkowski DT.A trip to the ER: coping with stress..Trends Cell Biol2004;14:20-8

[29] Leung T,Singh S,Krstic-Demonacos M.Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells..Breast Cancer Res2013;15:R107

[30] Pavlova NN.The emerging hallmarks of cancer metabolism..Cell Metab2016;23:27-47 PMCID:PMC4715268

[31] Liemburg-Apers DC,Koopman WJ.Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism..Arch Toxicol2015;89:1209-26 PMCID:PMC4508370

[32] Kang SW,Lee EK.ROS and energy metabolism in cancer cells: alliance for fast growth..Arch Pharm Res2015;38:338-45

[33] El Sayed SM,El Sawy SA,Fouad AM,Hashim MS,Kadry ZM,Gabr AG,Nabo MM.Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect)..Med Hypotheses2013;81:866-70

[34] Vaclavikova R,Stribrna-Sarmanova J,Mrhalova M,Gut I.RNA expression of cytochrome P450 in breast cancer patients..Anticancer Res2007;27:4443-50

[35] Zheng J.Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)..Oncol Lett2012;4:1151-7 PMCID:PMC3506713

[36] Hu Y,Johansson I,Cross A,Badger TM.Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver..J Pharmacol Exp Ther1994;269:1286-91

[37] Pelkonen O,Hakkola J,Hukkanen J.Inhibition and induction of human cytochrome P450 enzymes: current status..Arch Toxicol2008;82:667-715

[38] Zorov DB,Sollott SJ.Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release..Physiol Rev2014;94:909-50 PMCID:PMC4101632

[39] Kroemer G,Brenner C.Mitochondrial Membrane Permeabilization in Cell Death..Physiol Rev2007;87:99-163

[40] Schattenberg JM.Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling..Redox biology2014;3:7-15 PMCID:PMC4218941

[41] Raza H,Robin MA.Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress..Diabetes2004;53:185-94

[42] Lvdan,Baodan,Huang L.Downregulation of CYP2E1 ameliorates oxidative stress and apoptosis..Heart2011;97:A69

[43] Jin M,Kumar A.Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway..Cell Death Dis2013;4:e554

[44] Lewis MD.Role of CYP2E1 activity in endoplasmic reticulum ubiquitination, proteasome association, and the unfolded protein response..Arch Biochem Biophys2005;436:237-45

[45] Nebert DW.The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis..Nat Rev Cancer2006;6:947-60

[46] Zangar RC,Verma S.Mechanisms that regulate production of reactive oxygen species by cytochrome P450..Toxicol Appl Pharmacol2004;199:316-31

[47] Namazi MR.Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link..J Autoimmune Dis2009;6:4 PMCID:PMC2708150

[48] Nizamutdinova IT,Son KH,Kang SS,Lee JH,Chang KC.Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells..Int J Oncol2008;33:485-91

[49] Kim DK,Jang HH,Kim JR,Jeong WI,Park TS,Park SB,Lee CH.Estrogen-related receptor gamma controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol..Gut2013;62:1044-54 PMCID:PMC3812689

[50] Aitken AE,Morgan ET.Regulation of drug-metabolizing enzymes and transporters in inflammation..Annu Rev Pharmacol Toxicol2006;46:123-49

[51] Das J,Manna P.Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation..Toxicology2010;269:24-34

[52] Das J,Manna P.Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1..Free Radic Res2010;44:340-55

[53] Cederbaum A.Nrf2 and antioxidant defense against CYP2E1 toxicity..Expert Opin Drug Metab Toxicol2009;5:1223-44

[54] Shutt DC,Aykin-Burns N.2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells..Cancer Biol Ther2010;9:853-61 PMCID:PMC3215774

[55] Ihrlund LS,Khan O.3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs..Mol Oncol2008;2:94-101 PMCID:PMC5527790

[56] Wickramasekera NT.Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication..Mitochondrion2014;16:26-37 PMCID:PMC4026364

[57] Rodriguez-Enriquez S,Gallardo-Perez JC,Quezada H,Marin-Hernandez A,Torres-Marquez ME.Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma..Int J Biochem Cell Biol2010;42:1744-51

[58] Doherty JR.Targeting lactate metabolism for cancer therapeutics..J Clin Invest2013;123:3685-92 PMCID:PMC3754272

[59] Echtay KS,St-Pierre J,Cadenas S,Harper JA,Morrison A,Clapham JC.Superoxide activates mitochondrial uncoupling proteins..Nature2002;415:96-9